CLOV — Clover Health Investments Share Price
0.000.00%
Last trade - 00:00- $344.58m
- $46.26m
- $2.03bn
- 31
- 62
- 50
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.2 | ||
| Price to Tang. Book | 1.22 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.17 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -67.37% | ||
| Return on Equity | -66.34% | ||
| Operating Margin | -10.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 1,472 | 3,476.69 | 2,033.72 | 1,275.17 | 1,336.25 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. The Company operates under two segments: Insurance and Non-Insurance. Through its Insurance segment, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's Non-Insurance segment consists of operations in connection with its participation in the Direct Contracting program. The Company’s subsidiaries include Clover Health Labs, LLC, Medical Service Professionals of NJ LLC, Clover HMO of New Jersey Inc., Clover Health Holdings, Inc. and Clover Health Partners, LLC.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 7th, 2021
- Public Since
- June 12th, 2020
- No. of Shareholders
- 642
- No. of Employees
- 552
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 495,799,625
- Address
- 3401 Mallory Lane, Suite 210, Suite 320, FRANKLIN, 37067
- Web
- https://www.cloverhealth.com/
- Phone
- +1 2014322133
- Contact
- Ryan Schmidt
- Auditors
- Ernst & Young LLP
Upcoming Events for CLOV
Q1 2024 Clover Health Investments Corp Earnings Call
Clover Health Investments Corp at Bank of America Health Care Conference
Clover Health Investments Corp at Leerink Partners Healthcare Crossroads Conference
Clover Health Investments Corp Annual Shareholders Meeting
Clover Health Investments Corp Annual Shareholders Meeting
Q2 2024 Clover Health Investments Corp Earnings Release
Similar to CLOV
23andMe Holding Co.
NASDAQ Global Select Market
Acadia Healthcare
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
FAQ
What is the Clover Health Investments share price?
As of Today at 19:05 UTC, shares in Clover Health Investments are trading at $0.70. This share price information is delayed by 15 minutes.
How has the Clover Health Investments share price performed this year?
Shares in Clover Health Investments last closed at $0.70 and the price had moved by -8.41% over the past 365 days. In terms of relative price strength the Clover Health Investments share price has underperformed the S&P500 Index by -26.12% over the past year.
What are the analyst and broker recommendations for Clover Health Investments?
The overall consensus recommendation for Clover Health Investments is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Clover Health Investments dividend yield?
Clover Health Investments does not currently pay a dividend.
Does Clover Health Investments pay a dividend?
Clover Health Investments does not currently pay a dividend.
When does Clover Health Investments next pay dividends?
Clover Health Investments does not currently pay a dividend.
How do I buy Clover Health Investments shares?
To buy shares in Clover Health Investments you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Clover Health Investments?
As of the previous close price of $0.70, shares in Clover Health Investments had a market capitalisation of $344.58m.
Where are Clover Health Investments shares listed?
Here are the trading details for Clover Health Investments:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: CLOV
What kind of share is Clover Health Investments?
Based on an overall assessment of its quality, value and momentum Clover Health Investments is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Clover Health Investments share price forecast for 2024?
The analyst consensus target price for shares in Clover Health Investments is $1.44. That is 107.19% above the last closing price of $0.70.
Analysts covering Clover Health Investments currently have a consensus Earnings Per Share (EPS) forecast of -$0.22 for the next financial year.
What is the trend in the Clover Health Investments share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clover Health Investments. Over the past six months, its share price has underperformed the S&P500 Index by -45.71%.
As of the last closing price of $0.70, shares in Clover Health Investments were trading -29.8% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Clover Health Investments PE Ratio?
The Clover Health Investments PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Clover Health Investments?
We do not have data on Clover Health Investments' directors